• SENSEX
    NIFTY 50
Healthcare

Biocon: The Pegfilgrastim opportunity

Updated : May 28, 2018 10:30 AM IST

Biosimilars are better propostions for companies.
The USFDA has approved Biocon's first biosimilar applications in the US in 2017,
Biocon: The Pegfilgrastim opportunity

You May Also Like

Live TV

recommended for you

Advertisement